top of page
Search

BIOTrialMed Proudly Sponsors the 2024 SAPA-DC Scientific Forum

  • zhangs88
  • Jul 16, 2024
  • 1 min read

April 25, 2024 BIOTrialMed, an innovative service provider of clinical trial management, is honored to announce its sponsorship of the 2024 SAPA-DC Scientific Forum. This prestigious event, hosted by the Sino-American Pharmaceutical Professionals Association - DC Chapter (SAPA-DC), will take place on April 25, 2024, in Washington, D.C.


Fostering Innovation and Collaboration


As a sponsor of the 2024 SAPA-DC Scientific Forum, BIOTrialMed reaffirms its commitment to advancing scientific dialogue and collaboration within the biopharmaceutical industry. The forum will bring together professionals from academia, industry, and regulatory bodies to discuss emerging trends, challenges, and opportunities in drug development and regulatory affairs.


“We are delighted to support the SAPA-DC Scientific Forum, which serves as a pivotal platform for knowledge exchange and networking among pharmaceutical professionals,” said Shane Zhang, CEO of BIOTrialMed. “This sponsorship underscores our dedication to fostering innovation and driving excellence in biopharmaceutical research.”


Engaging Sessions and Networking Opportunities


The forum will feature engaging scientific sessions, keynote presentations, and panel discussions led by experts in the field. Attendees can expect insightful discussions on topics ranging from precision medicine and regulatory updates to the latest advancements in drug discovery.


“We invite all attendees to visit our booth to learn more about BIOTrialMed’s innovative solutions and how we empower organizations to streamline clinical trials and enhance patient outcomes,” added John Smith.


About BIOTrialMed


BIOTrialMed is dedicated to transforming biopharmaceutical trial management through innovative solutions and strategic partnerships. With a focus on driving efficiency and success in clinical research, BIOTrialMed continues to support organizations worldwide in bringing life-changing therapies to market.


For media inquiries or further information, please email to admin@biotrialmed.com or call (410) 718-2908.



 
 
 

Comentários


bottom of page